Cramer: Potential Biotech Plays

Description:

"It is entirely possible that the hot money goes out of tech and into biotech, which has the added advantage of not having nearly as high a multiple as tech, especially given the shrinkage of the P/E's that biotech has undergone."

"I don't like the tape, but the money will go somewhere"

Here are Cramer's 3 biotech names.

Most Viewed Portfolios

View All

Articles

5 Large-Cap Stocks to Trade for Earnings Season Gains

07.24.14 | 10:40 AM

BALTIMORE (Stockpickr) -- The S&P 500 pushed its way into new highs yesterday, ending Wednesday's session at a new record once again. That new high...

3 Stocks Spiking on Big Volume

07.24.14 | 09:12 AM

DELAFIELD, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also trac...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter